share_log

Aditxt | CORRESP: CORRESP

Aditxt | CORRESP: CORRESP

Aditxt | CORRESP：信函
美股SEC公告 ·  2024/06/12 00:41

Moomoo AI 已提取核心信息

Aditxt, Inc., a biotech company, has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1. The company has proposed for the registration to become effective at 5:00 p.m. Eastern Time on June 13, 2024. This request was made under Rule 461 of the Securities Act of 1933. Aditxt's CEO, Amro Albanna, signed the request, which was submitted through the company's legal counsel, Sheppard Mullin Richter & Hampton LLP. The SEC has been asked to notify the company's counsel promptly upon the declaration of the Registration Statement's effectiveness.
Aditxt, Inc., a biotech company, has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1. The company has proposed for the registration to become effective at 5:00 p.m. Eastern Time on June 13, 2024. This request was made under Rule 461 of the Securities Act of 1933. Aditxt's CEO, Amro Albanna, signed the request, which was submitted through the company's legal counsel, Sheppard Mullin Richter & Hampton LLP. The SEC has been asked to notify the company's counsel promptly upon the declaration of the Registration Statement's effectiveness.
生物技术公司Aditxt正式要求美国证券交易委员会（SEC）加速其S-1表格的注册声明生效日期。公司提议注册生效时间为2024年6月13日美国东部时间下午5:00。该请求根据1933年证券法第461条的规定提出。Aditxt的CEO Amro Albanna签署了此请求，并通过公司的法律顾问Sheppard Mullin Richter & Hampton LLP提交。该公司已要求SEC在注册声明生效后尽快通知公司的律师。
生物技术公司Aditxt正式要求美国证券交易委员会（SEC）加速其S-1表格的注册声明生效日期。公司提议注册生效时间为2024年6月13日美国东部时间下午5:00。该请求根据1933年证券法第461条的规定提出。Aditxt的CEO Amro Albanna签署了此请求，并通过公司的法律顾问Sheppard Mullin Richter & Hampton LLP提交。该公司已要求SEC在注册声明生效后尽快通知公司的律师。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Evaxion Biotech
    EVAX
    -- 6.030
    PMGC Holdings
    ELAB
    -- 3.100
    Lantern Pharma
    LTRN
    -- 5.400
    Transcode Therapeutics
    RNAZ
    -- 7.040
    Neuphoria Therapeutics
    NEUP
    -- 4.390
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球股市新风口在哪里？
    ▪️加密货币政策能否利好crypto？ ▪️关税政策能否利好中概等海外资产？ ▪️在特朗普政策下，有哪些投资机会值得关注？ 展开
    离川普上台只有7天了～
    热门中概股
    追踪最热门的中概股实时资讯。